Prevail Therapeutics Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • PRVL
  • 1d-5.79%
  • 1w-4.57%
  • 1m-12.35%
  • 1y-18.36%
ATH
  • ATH Price$18.98
  • ATH Date2020-02-04
  • % since ATH-41.68%
  • % to ATH71.45%
ATL
  • ATL Price$8.05
  • ATL Date2019-08-08
  • % from ATL37.52%
  • Last Low Price$10.75
  • Last Low Date2020-03-18
  • % From Last Low2.98%
IPO
  • IPO Price$15.31
  • % Current ROI USD-27.69%
  • ATH Price$18.98
  • % ROI ATH 23,577.64%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="PRVL"]

Key Data [addtoany]

Current price $11.07
Sector Healthcare
Industry Biotechnology
Today's High/Low $12/$11.0699
Volume 64,730.00
Previous Close $11.75
52 Week High/Low $19.25/$9.02
Market Cap 402,025,088.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $-2.55
Annualized Dividend $0
$11.07
[addtoany]
Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity